DrugPatentWatch Database Preview

Eli Lilly And Co Company Profile

ELI LILLY AND CO has seven approved drugs.

There are fifteen US patents protecting ELI LILLY AND CO drugs.

There are two hundred and eighteen patent family members on ELI LILLY AND CO drugs in fifty-one countries and sixty-four supplementary protection certificates in thirteen countries.

International Patents:	218
US Patents:	15
Tradenames:	8
Ingredients:	7
NDAs:	7
Drug Master File Entries:	37
Patent Litigation for Eli Lilly And Co:	See patent lawsuits for Eli Lilly And Co
PTAB Cases with Eli Lilly And Co as patent owner:	See PTAB cases with Eli Lilly And Co as patent owner

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eli Lilly And Co	HUMALOG KWIKPEN	insulin lispro recombinant	SOLUTION;SUBCUTANEOUS	205747-001	May 26, 2015		RX	Yes	Yes	7,291,132	➤ Try a Free Trial	Y			➤ Try a Free Trial
Eli Lilly And Co	SARAFEM	fluoxetine hydrochloride	CAPSULE;ORAL	018936-008	Jul 6, 2000		DISCN	Yes	No		➤ Try a Free Trial				➤ Try a Free Trial
Eli Lilly And Co	PROZAC	fluoxetine hydrochloride	CAPSULE;ORAL	018936-001	Dec 29, 1987	AB1	RX	Yes	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Eli Lilly And Co	PROZAC	fluoxetine hydrochloride	CAPSULE;ORAL	018936-006	Dec 23, 1992	4,626,549*PED	➤ Try a Free Trial
Eli Lilly And Co	SARAFEM	fluoxetine hydrochloride	CAPSULE;ORAL	018936-008	Jul 6, 2000	4,971,998*PED	➤ Try a Free Trial
Eli Lilly And Co	PROZAC	fluoxetine hydrochloride	CAPSULE;ORAL	018936-003	Jun 15, 1999	4,626,549*PED	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Solution	30 mg/1.5 mL	➤ Subscribe	2013-01-29
➤ Subscribe	Tablets	5 mg and 10 mg	➤ Subscribe	2013-07-10

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
90035-8	Sweden	➤ Try a Free Trial	PRODUCT NAME: BARICITINIB; REG. NO/DATE: EU/1/16/1170 20170215
C/GB09/032	United Kingdom	➤ Try a Free Trial	PRODUCT NAME: PRASUGREL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/08/503/001 20090225; UK EU/1/08/503/002 20090225; UK EU/1/08/503/003 20090225; UK EU/1/08/503/004 20090225
C/GB00/022	United Kingdom	➤ Try a Free Trial	PRODUCT NAME: INSULIN GLARGINE (LANTUS) OPTIONALLY IN THE FORM OF ESTERS THEREOF OR PHYSIOLOGICALLY TOLERATED SALTS THEREOF.; REGISTERED: UK EU/1/00/134/001 20000609; UK EU/1/00/134/002 20000609; UK EU/1/00/134/003 20000609; UK EU/1/00/134/004 20000609; UK EU/1/00/134/005 20000609; UK EU/1/00/134/006 20000609; UK EU/1/00/134/007 20000609
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.